IBRNvsIGSB
iShares Neuroscience and Healthcare ETF against iShares 1-5 Year Investment Grade Corporate Bond ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | IGSB | |
|---|---|---|
| Expense ratio | 0.47% | 0.040% |
| Assets | $6M | $23.3B |
| Net flow, 1 month | −$60K | +$135M |
| Net flow, 1 year | +$2M | +$2.6B |
| Return, YTD | -0.9% | -3.2% |
| Return, 1 year | +15.3% | -3.2% |
| Avg daily volume | 2K | 5.3M |
| Holdings | 54 | 3892 |
| Listed | Aug 24, 2022 | Jan 5, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS